Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gersande Lena is active.

Publication


Featured researches published by Gersande Lena.


Journal of Medicinal Chemistry | 2008

Dihydrofuro[3,4-c]pyridinones as inhibitors of the cytolytic effects of the pore-forming glycoprotein perforin

Gersande Lena; Joseph A. Trapani; Vivien R. Sutton; Annette Ciccone; Kylie A. Browne; Mark J. Smyth; William A. Denny; Julie A. Spicer

Dihydrofuro[3,4-c]pyridinones are the first class of small molecules reported to inhibit the cytolytic effects of the lymphocyte toxin perforin. A lead structure was identified from a high throughput screen, and a series of analogues were designed and prepared to explore structure-activity relationships around the core bicyclic thioxofuropyridinone and pendant furan ring. This resulted in the identification of a submicromolar inhibitor of the perforin-induced lysis of Jurkat T-lymphoma cells.


Journal of Medicinal Chemistry | 2013

Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin.

Julie A. Spicer; Gersande Lena; Dani M. Lyons; Kristiina M. Huttunen; Christian Miller; Patrick D. O'Connor; Matthew Bull; Nuala A. Helsby; Stephen M.F. Jamieson; William A. Denny; Annette Ciccone; Kylie A. Browne; Jamie A. Lopez; Jesse A. Rudd-Schmidt; Ilia Voskoboinik; Joseph A. Trapani

A series of novel 5-arylidene-2-thioxoimidazolidin-4-ones were investigated as inhibitors of the lymphocyte-expressed pore-forming protein perforin. Structure–activity relationships were explored through variation of an isoindolinone or 3,4-dihydroisoquinolinone subunit on a fixed 2-thioxoimidazolidin-4-one/thiophene core. The ability of the resulting compounds to inhibit the lytic activity of both isolated perforin protein and perforin delivered in situ by natural killer cells was determined. A number of compounds showed excellent activity at concentrations that were nontoxic to the killer cells, and several were a significant improvement on previous classes of inhibitors, being substantially more potent and soluble. Representative examples showed rapid and reversible binding to immobilized mouse perforin at low concentrations (≤2.5 μM) by surface plasmon resonance and prevented formation of perforin pores in target cells despite effective target cell engagement, as determined by calcium influx studies. Mouse PK studies of two analogues showed T1/2 values of 1.1–1.2 h (dose of 5 mg/kg iv) and MTDs of 60–80 mg/kg (ip).


Chemical Communications | 2006

Porous 3-D honeycomb architecture by self-assembly of helical H-bonded molecular tapes

Arnaud-Pierre Schaffner; Gersande Lena; Solveig Roussel; Anne Wawrezinieck; André Aubry; Jean-Paul Briand; Claude Didierjean; Gilles Guichard

Enantiopure dipeptide-derived 1,3,5-triazepan-2,6-diones and form H-bonded 3(1) helical molecular tapes with P chirality in the solid state; in the case of , these columnar tapes self-assemble through aromatic-aromatic interactions to give hollow tubular structures.


Journal of Medicinal Chemistry | 2006

In silico-guided target identification of a scaffold-focused library : 1,3,5 -triazepan -2,6 -diones as novel phospholipase A2 inhibitors

Pascal Muller; Gersande Lena; Eric Boilard; Sofiane Bezzine; Gérard Lambeau; and Gilles Guichard; Didier Rognan


Chemistry: A European Journal | 2006

1,3,5-Triazepan-2,6-diones as Structurally Diverse and Conformationally Constrained Dipeptide Mimetics: Identification of Malaria Liver Stage Inhibitors from a Small Pilot Library

Gersande Lena; Eliette Lallemand; Anne Charlotte Grüner; Joel Boeglin; Solveig Roussel; Arnaud-Pierre Schaffner; André Aubry; Jean-François Franetich; Dominique Mazier; I. Landau; Jean-Paul Briand; Claude Didierjean; Laurent Rénia; Gilles Guichard


Current Organic Chemistry | 2008

Synthetic Methods for the Preparation of Triazepandiones and Review of their Applications

Gersande Lena; Gilles Guichard


Archive | 2006

COMPOSITIONS AND METHODS FOR THE INHIBITION OF PHOSPHOLIPASE A2

Gilles Guichard; Gersande Lena; Pascal Muller; Didier Rognan; Gérard Lambeau; Eric Boilard


Acta Crystallographica Section E-structure Reports Online | 2007

7-Isopropyl-5-methyl-1,3,5-triazepan-2,6-dione deuterated chloroform 0.94-solvate

Emmanuel Aubert; Gersande Lena; Martine Gellenoncourt; Eric Durain; Gilles Guichard; Claude Didierjean


Advances in Experimental Medicine and Biology | 2009

1,3,5-Triazepan-2,6-diones as conformationally constrained dipeptide mimetics. In silico guided identification of sPLA2 inhibitors

Gilles Guichard; Gersande Lena; Joel Boeglin; Pascal Muller; Eric Boilard; Gérard Lambeau; Didier Rognan; Claude Didierjean


Archive | 2006

AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS

Guichard Gilles; Gersande Lena; Eliette Lallemand; Laurent Rénia

Collaboration


Dive into the Gersande Lena's collaboration.

Top Co-Authors

Avatar

Gilles Guichard

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Didier Rognan

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar

Gérard Lambeau

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Jean-Paul Briand

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Pascal Muller

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

André Aubry

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Arnaud-Pierre Schaffner

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Eric Boilard

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge